公司参加2025年美国西部医药原料及植物提取物展览会 The company participated in the 2025 West Coast Exhibition for Pharmaceutical Ingredients and Plant Extracts in the United States
公司参加2025年美国西部医药原料及植物提取物展览会
2025年当地时间10月29日-30日，美国西部医药原料及植物提取物展览会在美国拉斯维加斯盛大举办，公司董事长罗翀带业务团队携公司核心产品芦丁、槲皮素、甘露糖等植物提取物产品亮相展会现场，向全球客商推介公司核心产品及企业实力。
美国西部医药原料及植物提取物展览会已成功举办27届，并发展成为美国规模最大的天然提取物、保健品原料及食品添加剂行业的国际性展会。吸引了超1500家企业参展，其中中国企业数量近500家，创下历届新高。也是公司开拓国际市场、洞悉行业前沿、了解技术与产品进步和发展趋势重要平台。
展会期间，公司展台前客商络绎不绝，业务团队以热情专业的态度，向新老客户详细介芦丁、槲皮素、鼠李糖等植物提取物优势产品，与老客户沟通解决当前合作中遇到的问题困难，商讨2026年度新合同订单，业务洽谈取得积极成果。
北美市场是医药原料最重要的终端市场，引领着行业发展方向，是企业产品加快“走出去”的重要目的地。下一步，公司将锚定国际原料市场需求，以产品质量为核心竞争力，以服务保障为合作基石，持续加大国际市场开发力度，不断提升国际化经营水平。
The company participated in the 2025 West Coast Exhibition for Pharmaceutical Ingredients and Plant Extracts in the United States
From October 29 to 30 local time, 2025,the West Coast Exhibition for Pharmaceutical Ingredients and Plant Extracts was grandly held in Las Vegas, USA. Chairman Luo Chong led the company's business team to showcase core products—including rutin, quercetin, mannose, and other plant extracts—at the exhibition, promoting the company's flagship offerings and overall capabilities to global buyers.
The West Coast Exhibition for Pharmaceutical Ingredients and Plant Extracts has been successfully held for 27 editions and has grown into the largest international trade show in the United States dedicated to natural extracts, dietary supplement ingredients, and food additives. This year' event attracted more than 1,500 exhibitors, including nearly 500 Chinese companies—a record high in the exhibition's history. For our company, it serves as a vital platform to expand into international markets, gain insights into industry frontiers, and stay abreast of the latest advancements and trends in technology and products.
During the exhibition, the company’s booth was continuously visited by a steady stream of buyers. The business team, with enthusiasm and professionalism, provided detailed introductions to both new and existing clients about the company's key plant extract products—such as rutin, quercetin, and rhamnose. They also engaged in discussions with long-standing customers to address current challenges in their collaborations and negotiated new contracts and orders for 2026, achieving positive outcomes in business discussions.
The North American market is the most important end-market for pharmaceutical ingredients, setting the trend for industry development and serving as a key destination for accelerating the company's global expansion. Going forward, the company will closely align with international demand for raw materials, taking product quality as its core competitive advantage and service reliability as the foundation for collaboration. It will continue to intensify efforts in international market development and steadily enhance its global operational capabilities.